SCHEMBL14864456

SCHEMBL14864456

Cc1cccc(-c2cc3ccc(C(N)=O)cn3c2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 2/20 0.51
▸ PARP1 P09874 2/20 0.49
▸ CSF1R P07333 1/20 0.42
▸ FLT1 P17948 1/20 0.42
▸ FLT3 P36888 1/20 0.42
▸ HSD17B1 P14061 1/20 0.41
▸ HSD17B2 P37059 1/20 0.41
▸ TLR8 Q9NR97 2/20 0.40
▸ CSNK1D P48730 1/20 0.40
▸ CSNK1E P49674 1/20 0.40
▸ MAPK14 Q16539 1/20 0.40
▸ NR4A2 P43354 1/20 0.39
▸ ICMT O60725 2/20 0.39
▸ RIPK2 O43353 1/20 0.39
▸ BRD4 O60885 1/20 0.39
▸ BRD9 Q9H8M2 1/20 0.39
▸ HDAC6 Q9UBN7 1/20 0.39
▸ PARP15 Q460N3 1/20 0.38
▸ PARP10 Q53GL7 1/20 0.38
▸ CNR2 P34972 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13412869 0.81 NR4A2 (0.36) DHODHPARP1NR4A2BRD4BRD9
SCHEMBL1852275 0.79 TSHR (0.54) HDAC2
SCHEMBL12394209 0.77 DHODH (0.64) DHODHPARP1CSF1RFLT1FLT3
SCHEMBL5605353 0.75 PARP1 (0.78) DHODHPARP1CSF1RFLT1FLT3
SCHEMBL1848238 0.75 MAP4K4 (0.55) PARP1BRD4BRD9PARP10
SCHEMBL7169894 0.71 EGFR (0.46) DHODH
SCHEMBL3884828 0.71 SMN1; SMN2 (0.58) —
Terephthalamide SCHEMBL5060544 0.71 PARP1 (0.76) DHODHPARP1CSF1RFLT1FLT3
SCHEMBL18120863 0.68 DHODH (1.00) DHODHPARP1CSF1RFLT1FLT3
SCHEMBL30108216 0.68 DHODH (0.60) DHODHPARP1CSF1RFLT1FLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8420052-B2 Imaging agents useful for identifying AD pathology SIEMENS MEDICAL SOLUTIONS USA, INC. (US) 2013-04-16 — — US disclosed
Send feedback